We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INVA market cap is 964.85M. The company's latest EPS is USD 2.8425 and P/E is 5.37.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 67.26M | 65.8M | 76.37M | 80.99M | 67.26M |
| Operating Income | -45.35M | 24.18M | 29.9M | 28.52M | 85.83M |
| Net Income | 265.52M | -68.31M | 34.87M | 1.28M | 82.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 261.02M | 336.79M | 391.87M | 331.34M | 310.46M |
| Operating Income | 246.36M | 321.12M | 375.1M | 207M | 113.89M |
| Net Income | 157.29M | 224.4M | 265.85M | 213.92M | 179.72M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.33B | 1.23B | 1.13B | 1.12B | 1.19B |
| Total Liabilities | 686.34M | 665.71M | 568.28M | 563.15M | 560.61M |
| Total Equity | 641.37M | 565.79M | 561.49M | 555.09M | 627.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 724.83M | 999.57M | 926.4M | 1.23B | 1.24B |
| Total Liabilities | 382.71M | 391.73M | 400.46M | 665.71M | 568.55M |
| Total Equity | 342.12M | 607.84M | 525.94M | 565.79M | 674.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 192.83M | 201.73M | 25.68M | 63.87M | 107.81M |
| Investing | -47.96M | -56.63M | -35.72M | -35.72M | -61.61M |
| Financing | -45.57M | -55.57M | -136.96M | -146.17M | -157.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 257.46M | 313.11M | 363.81M | 201.73M | 141.06M |
| Investing | -18M | -314.94M | 43.72M | -56.63M | -66.76M |
| Financing | -23.78M | -29.79M | -452.5M | -55.57M | -171.84M |
| Market Cap | 964.85M |
| Price to Earnings Ratio | 5.37 |
| Price to Sales Ratio | 3.11 |
| Price to Cash Ratio | 4.99 |
| Price to Book Ratio | 1.43 |
| Dividend Yield | - |
| Shares Outstanding | 63.23M |
| Average Volume (1 week) | 818.52k |
| Average Volume (1 Month) | 650.61k |
| 52 Week Change | 31.21% |
| 52 Week High | 16.865 |
| 52 Week Low | 11.3701 |
| Spread (Intraday) | 0.94 (6.08%) |
| Company Name | Innoviva Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
